Johnson & Johnson receives FDA approval for soft tissue surgical robot

Johnson & Johnson received FDA approval for the Ottava soft tissue surgical robot.

The approval marks Johnson & Johnson's first US regulatory authorization for a robotic surgery device.

Ottava is designed for soft tissue surgery, a rapidly growing segment of the surgical market.